Etanercept - Latest Advances

Successful treatment of post-transplant steroid-refractory idiopathic pneumonia syndrome with etanercept and mycophenolate mofetil

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 07, 2025

Efficacy and Safety of Biologics in the Treatment of Pediatric Psoriatic Arthritis: A Systematic Review.

Journal: Journal of cutaneous medicine and surgery

Published: December 05, 2025

snoRNA Snord3 promotes rheumatoid arthritis by epigenetic regulation of ESM1 in fibroblast-like synoviocytes in mice.

Journal: Science translational medicine

Published: November 12, 2025

Evaluating the Safety and Effectiveness of Perispinal Etanercept for Post-Stroke Recovery: A Systematic Review.

Journal: Cureus

Published: November 12, 2025

Comparison of the Risk of Paradoxical Psoriasis between Monoclonal Antibody and Non-monoclonal Antibody Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis: An Observational Study Using a Claims Database.

Journal: Biological & pharmaceutical bulletin

Published: November 05, 2025

The value of skin testing with tumor necrosis factor-inhibitors in patients with local and systemic hypersensitivity reactions.

Journal: Allergy and asthma proceedings

Published: October 29, 2025

Palmar fasciitis and polyarthritis syndrome with esophageal carcinoma: A case report and review of the literature.

Journal: Modern rheumatology case reports

Published: September 30, 2025

Hypersensitivity reactions to biologics in chronic rheumatic diseases: prevalence and associated factors.

Journal: Expert opinion on drug safety

Published: September 26, 2025

Immune checkpoint inhibitor-induced toxic epidermal necrolysis responding to repeated dosing of adjuvant therapy with etanercept.

Journal: JAAD case reports

Published: September 25, 2025

Drug-induced osteoporosis/osteopenia: a pharmacovigilance analysis using the FDA Adverse Event Reporting System database.

Journal: Clinical and experimental rheumatology

Published: September 22, 2025

Effectiveness of "tumor necrosis factor inhibitors" in monogenic hereditary recurrent fevers in children and adolescents: a systematic review.

Journal: Frontiers in immunology

Published: September 21, 2025

Feasibility of Rapid Regulatory Differentiation of TNF Receptor 2-Fc Fusion Protein Products from Various Manufacturers in the Chinese Market Using a Novel Mass Spectrometry-Based Multi-attribute Method (MAM).

Journal: Journal of the American Society for Mass Spectrometry

Published: September 18, 2025

Filters

Successful treatment of post-transplant steroid-refractory idiopathic pneumonia syndrome with etanercept and mycophenolate mofetil

Successful treatment of post-transplant steroid-refractory idiopathic pneumonia syndrome with etanercept and mycophenolate mofetil

Efficacy and Safety of Biologics in the Treatment of Pediatric Psoriatic Arthritis: A Systematic Review.

Efficacy and Safety of Biologics in the Treatment of Pediatric Psoriatic Arthritis: A Systematic Review.

snoRNA Snord3 promotes rheumatoid arthritis by epigenetic regulation of ESM1 in fibroblast-like synoviocytes in mice.

snoRNA Snord3 promotes rheumatoid arthritis by epigenetic regulation of ESM1 in fibroblast-like synoviocytes in mice.

Evaluating the Safety and Effectiveness of Perispinal Etanercept for Post-Stroke Recovery: A Systematic Review.

Evaluating the Safety and Effectiveness of Perispinal Etanercept for Post-Stroke Recovery: A Systematic Review.

Comparison of the Risk of Paradoxical Psoriasis between Monoclonal Antibody and Non-monoclonal Antibody Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis: An Observational Study Using a Claims Database.

Comparison of the Risk of Paradoxical Psoriasis between Monoclonal Antibody and Non-monoclonal Antibody Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis: An Observational Study Using a Claims Database.

The value of skin testing with tumor necrosis factor-inhibitors in patients with local and systemic hypersensitivity reactions.

The value of skin testing with tumor necrosis factor-inhibitors in patients with local and systemic hypersensitivity reactions.

Palmar fasciitis and polyarthritis syndrome with esophageal carcinoma: A case report and review of the literature.

Palmar fasciitis and polyarthritis syndrome with esophageal carcinoma: A case report and review of the literature.

Hypersensitivity reactions to biologics in chronic rheumatic diseases: prevalence and associated factors.

Hypersensitivity reactions to biologics in chronic rheumatic diseases: prevalence and associated factors.

Immune checkpoint inhibitor-induced toxic epidermal necrolysis responding to repeated dosing of adjuvant therapy with etanercept.

Immune checkpoint inhibitor-induced toxic epidermal necrolysis responding to repeated dosing of adjuvant therapy with etanercept.

Drug-induced osteoporosis/osteopenia: a pharmacovigilance analysis using the FDA Adverse Event Reporting System database.

Drug-induced osteoporosis/osteopenia: a pharmacovigilance analysis using the FDA Adverse Event Reporting System database.

Effectiveness of "tumor necrosis factor inhibitors" in monogenic hereditary recurrent fevers in children and adolescents: a systematic review.

Effectiveness of "tumor necrosis factor inhibitors" in monogenic hereditary recurrent fevers in children and adolescents: a systematic review.

Feasibility of Rapid Regulatory Differentiation of TNF Receptor 2-Fc Fusion Protein Products from Various Manufacturers in the Chinese Market Using a Novel Mass Spectrometry-Based Multi-attribute Method (MAM).

Feasibility of Rapid Regulatory Differentiation of TNF Receptor 2-Fc Fusion Protein Products from Various Manufacturers in the Chinese Market Using a Novel Mass Spectrometry-Based Multi-attribute Method (MAM).